• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤免疫与自身免疫的偶联和解偶联。

Coupling and uncoupling of tumor immunity and autoimmunity.

作者信息

Bowne W B, Srinivasan R, Wolchok J D, Hawkins W G, Blachere N E, Dyall R, Lewis J J, Houghton A N

机构信息

Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

出版信息

J Exp Med. 1999 Dec 6;190(11):1717-22. doi: 10.1084/jem.190.11.1717.

DOI:10.1084/jem.190.11.1717
PMID:10587362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2195744/
Abstract

Self-antigens, in the form of differentiation antigens, are commonly recognized by the immune system on melanoma and other cancers. We have shown previously that active immunization of mice against the melanocyte differentiation antigen, a tyrosinase-related protein (TRP) gp75(TRP-1) (the brown locus protein) expressed by melanomas, could induce tumor immunity and autoimmunity manifested as depigmentation. In this system, tumor immunity and autoimmunity were mediated by autoantibodies. Here, we characterize immunity against another tyrosinase family glycoprotein TRP-2 (the slaty locus protein), using the same mouse model and method of immunization. As observed previously for gp75(TRP-1), immunity was induced by DNA immunization against a xenogeneic form of TRP-2, but not against the syngeneic gene, and depended on CD4(+) cells. Immunization against TRP-2 induced autoantibodies and autoreactive cytotoxic T cells. In contrast to immunization against gp75(TRP-1), both tumor immunity and autoimmunity required CD8(+) T cells, but not antibodies. Only autoimmunity required perforin, whereas tumor immunity proceeded in the absence of perforin. Thus, immunity induced against two closely related autoantigens that are highly conserved throughout vertebrate evolution involved qualitatively different mechanisms, i.e., antibody versus CD8(+) T cell. However, both pathways led to tumor immunity and identical phenotypic manifestations of autoimmunity.

摘要

以分化抗原形式存在的自身抗原通常会被黑色素瘤和其他癌症的免疫系统识别。我们之前已经表明,主动免疫小鼠使其针对黑色素细胞分化抗原,即黑色素瘤表达的一种酪氨酸酶相关蛋白(TRP)gp75(TRP - 1)(棕色位点蛋白),可诱导肿瘤免疫和表现为色素脱失的自身免疫。在这个系统中,肿瘤免疫和自身免疫是由自身抗体介导的。在此,我们使用相同的小鼠模型和免疫方法,对针对另一种酪氨酸酶家族糖蛋白TRP - 2(石板色位点蛋白)的免疫进行了表征。如之前对gp75(TRP - 1)所观察到的,通过针对异种形式的TRP - 2进行DNA免疫可诱导免疫,但针对同基因基因则不能,且这种免疫依赖于CD4(+)细胞。针对TRP - 2的免疫诱导了自身抗体和自身反应性细胞毒性T细胞。与针对gp75(TRP - 1)的免疫不同,肿瘤免疫和自身免疫都需要CD8(+) T细胞,但不需要抗体。只有自身免疫需要穿孔素,而肿瘤免疫在没有穿孔素的情况下也能进行。因此,针对在整个脊椎动物进化过程中高度保守的两种密切相关自身抗原所诱导的免疫涉及质的不同机制,即抗体介导与CD8(+) T细胞介导。然而,这两条途径都导致了肿瘤免疫和相同表型的自身免疫表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6226/2195744/8f4d5f4f3bc7/JEM991601.f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6226/2195744/2ef6e3f2991f/JEM991601.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6226/2195744/c5d3c8f769fd/JEM991601.f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6226/2195744/6fcfa98040a5/JEM991601.f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6226/2195744/9b2f7c85006b/JEM991601.f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6226/2195744/8f4d5f4f3bc7/JEM991601.f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6226/2195744/2ef6e3f2991f/JEM991601.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6226/2195744/c5d3c8f769fd/JEM991601.f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6226/2195744/6fcfa98040a5/JEM991601.f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6226/2195744/9b2f7c85006b/JEM991601.f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6226/2195744/8f4d5f4f3bc7/JEM991601.f4.jpg

相似文献

1
Coupling and uncoupling of tumor immunity and autoimmunity.肿瘤免疫与自身免疫的偶联和解偶联。
J Exp Med. 1999 Dec 6;190(11):1717-22. doi: 10.1084/jem.190.11.1717.
2
Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein.暗示自身免疫识别在肿瘤排斥反应中的作用:针对棕色位点蛋白的被动免疫。
J Exp Med. 1995 Nov 1;182(5):1609-14. doi: 10.1084/jem.182.5.1609.
3
Tumor immunity and autoimmunity induced by immunization with homologous DNA.同源DNA免疫诱导的肿瘤免疫和自身免疫
J Clin Invest. 1998 Sep 15;102(6):1258-64. doi: 10.1172/JCI4004.
4
Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens.γ干扰素在针对编码相关黑素小体抗原的DNA疫苗的免疫反应中的其他作用。
Cancer Immun. 2001 Aug 16;1:9.
5
Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2.黑色素瘤抗原gp100和TRP-2多次免疫诱导的治疗性肿瘤免疫
Cancer Res. 2001 Feb 1;61(3):859-63.
6
Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity.由改变的抗原诱导的对分化抗原的免疫反应:肿瘤排斥与自身免疫的研究
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14809-14. doi: 10.1073/pnas.93.25.14809.
7
Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity.用编码gp100的DNA进行免疫可产生不依赖CD4 T细胞的抗肿瘤免疫。
Surgery. 2000 Aug;128(2):273-80. doi: 10.1067/msy.2000.107421.
8
Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.用“自身”酪氨酸酶相关蛋白2进行基因疫苗接种可根除黑色素瘤,但不会导致白癜风。
Cancer Res. 2000 Jan 15;60(2):253-8.
9
Melanoma progression despite infiltration by in vivo-primed TRP-2-specific T cells.尽管体内预致敏的TRP-2特异性T细胞浸润,黑色素瘤仍进展。
J Immunother. 2009 Feb-Mar;32(2):129-39. doi: 10.1097/CJI.0b013e31819144d7.
10
Ubiquitin-fusion degradation pathway plays an indispensable role in naked DNA vaccination with a chimeric gene encoding a syngeneic cytotoxic T lymphocyte epitope of melanocyte and green fluorescent protein.泛素融合降解途径在用编码黑色素细胞同基因细胞毒性T淋巴细胞表位和绿色荧光蛋白的嵌合基因进行裸DNA疫苗接种过程中发挥着不可或缺的作用。
Immunology. 2004 Aug;112(4):567-74. doi: 10.1111/j.1365-2567.2004.01916.x.

引用本文的文献

1
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma.病毒分子模拟影响鼠类和人类黑色素瘤的抗肿瘤免疫反应。
Cancer Immunol Res. 2021 Aug;9(8):981-993. doi: 10.1158/2326-6066.CIR-20-0814. Epub 2021 Jun 8.
2
CD8 T cell self-tolerance permits responsiveness but limits tissue damage.CD8 T 细胞自身耐受允许应答,但限制组织损伤。
Elife. 2021 Apr 30;10:e65615. doi: 10.7554/eLife.65615.
3
Mechanisms of melanocyte death in vitiligo.白癜风中黑素细胞死亡的机制。

本文引用的文献

1
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.用编码“自身”抗原的重组痘苗病毒进行疫苗接种可诱导小鼠发生自身免疫性白癜风和肿瘤细胞破坏:CD4(+) T淋巴细胞的需求。
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2982-7. doi: 10.1073/pnas.96.6.2982.
2
Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2).从黑色素瘤抗原酪氨酸酶相关蛋白2(TRP2)中鉴定出一个共享的HLA-A*0201限制性T细胞表位。
Cancer Res. 1998 Nov 1;58(21):4895-901.
3
Tumor immunity and autoimmunity induced by immunization with homologous DNA.
Med Res Rev. 2021 Mar;41(2):1138-1166. doi: 10.1002/med.21754. Epub 2020 Nov 17.
4
Non-Thermal Plasma-Induced Immunogenic Cell Death in Cancer: A Topical Review.非热等离子体诱导癌症中的免疫原性细胞死亡:综述
J Phys D Appl Phys. 2019 Oct 22;52(42). doi: 10.1088/1361-6463/ab31c1. Epub 2019 Aug 6.
5
Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity.I 型干扰素阻断可分离免疫疗法诱导的抗肿瘤免疫和自身免疫毒性。
J Clin Invest. 2019 Feb 1;129(2):518-530. doi: 10.1172/JCI121004. Epub 2018 Dec 18.
6
Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis.腹膜转移瘤腹腔内免疫治疗的早期研究与最新进展
Vaccines (Basel). 2018 Aug 10;6(3):54. doi: 10.3390/vaccines6030054.
7
B7-H1 maintains the polyclonal T cell response by protecting dendritic cells from cytotoxic T lymphocyte destruction.B7-H1 通过保护树突状细胞免受细胞毒性 T 淋巴细胞的破坏来维持多克隆 T 细胞反应。
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):3126-3131. doi: 10.1073/pnas.1722043115. Epub 2018 Mar 5.
8
Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial.用TRP-2 mRNA电穿孔的朗格汉斯型树突状细胞刺激针对黑色素瘤的细胞免疫:一项I期疫苗试验的结果。
Oncoimmunology. 2017 Sep 21;7(1):e1372081. doi: 10.1080/2162402X.2017.1372081. eCollection 2017.
9
DNA vaccines for prostate cancer.用于前列腺癌的DNA疫苗。
Pharmacol Ther. 2017 Jun;174:27-42. doi: 10.1016/j.pharmthera.2017.02.016. Epub 2017 Feb 7.
10
Intraperitoneal immunotherapy: historical perspectives and modern therapy.腹腔内免疫疗法:历史回顾与现代治疗
Cancer Gene Ther. 2016 Nov;23(11):373-381. doi: 10.1038/cgt.2016.49. Epub 2016 Nov 11.
同源DNA免疫诱导的肿瘤免疫和自身免疫
J Clin Invest. 1998 Sep 15;102(6):1258-64. doi: 10.1172/JCI4004.
4
gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand.gp100/pmel 17是一种小鼠肿瘤排斥抗原:利用高亲和力、改变的肽配体诱导“自身”反应性、杀肿瘤T细胞。
J Exp Med. 1998 Jul 20;188(2):277-86. doi: 10.1084/jem.188.2.277.
5
B cells inhibit induction of T cell-dependent tumor immunity.B细胞抑制T细胞依赖性肿瘤免疫的诱导。
Nat Med. 1998 May;4(5):627-30. doi: 10.1038/nm0598-627.
6
Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33.在HLA - A31和 - A33背景下,细胞毒性T淋巴细胞(CTL)对源自酪氨酸酶相关蛋白 - 2的抗原肽的识别。
J Immunol. 1998 Jan 15;160(2):890-7.
7
Fc receptors are required in passive and active immunity to melanoma.Fc受体在对黑色素瘤的被动免疫和主动免疫中是必需的。
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):652-6. doi: 10.1073/pnas.95.2.652.
8
Melanosomal proteins as melanoma-specific immune targets.黑素小体蛋白作为黑色素瘤特异性免疫靶点。
Melanoma Res. 1997 Apr;7(2):83-95. doi: 10.1097/00008390-199704000-00001.
9
Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma.鉴定酪氨酸酶相关蛋白2为B16黑色素瘤的肿瘤排斥抗原。
J Exp Med. 1997 Feb 3;185(3):453-9. doi: 10.1084/jem.185.3.453.
10
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes.鉴定TRP-2作为一种可被细胞毒性T淋巴细胞识别的人类肿瘤抗原。
J Exp Med. 1996 Dec 1;184(6):2207-16. doi: 10.1084/jem.184.6.2207.